Unique business model

About M1 Kliniken AG

With the guiding principle of "highest quality at the best price", M1 has become the leading brand for beauty medicine in Germany. Along with Berlin based M1 Schlossklinik - one of the largest and most modern specialist surgical clinics in Europe, M1 Kliniken AG operates a network of specialist centres for aesthetic medical treatments under the brands "M1 Med Beauty", "M1 Laser" and "M1 Dental". We are also growing internationally. In addition, the M1 markets high-quality products to private customers as well as doctors, pharmacies and wholesalers. M1 has been listed on the stock exchange since 2015.


Strategy & goals

The strategic goal of the M1 Kliniken Group is to offer high quality medical services. Beauty products, beauty treatments and aesthetic surgeries are subject to high price sensitivity. The German Society for Consumer Research (GfK) has identified that the average market prices for breast surgery, liopsuction and wrinkle treatment are too expensive from the customer's point of view. The range of products and services offered by M1 Kliniken Group is therefore based on the price expectations of customers. By offering the highest quality at the best price, the demand for beauty treatments and aesthetic surgeries is increasing and new customer groups are being established.

Latest news

| Corporate News

  • Group revenues decrease by only 12 % to 29.1 million Euro despite loss of about 1/3 of treatment days
  • Consolidated net income of 2.0 million Euro
  • High utilization of the specialized centers after resumption of patient treatments

| Corporate News

Yesterday, M1 Kliniken AG successfully held its Annual General Meeting 2020. In his presentation, the Management Board gave an outline of the company's prosperous development in the 2019 financial year, which was accompanied by a significant …

| Corporate News

M1 Kliniken AG acquires about 48 % of the share capital of HAEMATO AG from MPH Health Care AG. Transfer of the HAEMATO shares within the framework of a capital increase through contribution in kind Focus of both companies on their respective core …

| Ad-hoc news

M1 Kliniken AG acquires ca. 48% of the shares of HAEMATO AG - transfer of the shares in a capital increase against contribution in kind of M1 Kliniken AG